Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Myricetin ameliorates prediabetes through gut microbiota–SCFAs–Gpr43 axis — Yang Li (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Myricetin ameliorates prediabetes through gut microbiota–SCFAs–Gpr43 axis
Shared by
Jianbo Xiao
Universidade de Vigo
Myricetin ameliorates prediabetes through gut microbiota–SCFAs–Gpr43 axis
Article
2024
en
Authors
+4 more
YL
Yang Li
YG
Yongchao Gao
JG
Jupeng Gong
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Myricetin ameliorated prediabetes via immunomodulation and gut microbiota interaction
Yang Li
,
Yongchao Gao
,
Jupeng Gong
,
Hui Wang
,
Mohamed A. Farag
,
Jesus Simal Gandara
,
Yonghua Zhao
,
Shaoping Nie
,
Jianbo Xiao
Article
2025
MYR ameliorated MSG-induced immune dysfunction in HFD mice via modulation of gut microbiota and SCFAs metabolism
Qiaoling Su
,
Yang Li
,
Jianbo Xiao
,
Hui Cao
,
Hui Wang
Article
2020
The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression
Leszek Rudzki
,
Michael Maes
Article
2022
Shenqi compound ameliorates type-2 diabetes mellitus by modulating the gut microbiota and metabolites
Xiyu Zhang
,
Heting Wang
,
Chunguang Xie
,
Zhipeng Hu
,
Yuan Zhang
,
Sihan Peng
,
Yuchi He
,
Jian Jian Kang
,
Hong Gao
,
Haipo Yuan
,
Ya Liu
,
Gang Fan
Article
2024
Myricetin attenuates the inflammatory bowel disease in prediabetic mice <i>via</i> inflammation inhibition and gut microbiota modulation
Yang Li
,
Yongchao Gao
,
Hui Wang
,
Weizhi Zhong
,
Jupeng Gong
,
Mohamed A. Farag
,
Yonghua Zhao
,
Jianbo Xiao
Discussion(0)
No comments yet. Be the first to comment.